Furthermore, immunohistochemical analysis in paired tumour tissue biopsies taken before and during weekly dosing (20, 50, or 70 mg) confirmed inhibition of S6K1 at doses ⩾20 mg (Tabernero et al, 2008). This evidence concerns the gene RPS6KB1 and neoplasm.